A detailed history of Smith Anglin Financial, LLC transactions in Elevance Health, Inc. stock. As of the latest transaction made, Smith Anglin Financial, LLC holds 399 shares of ELV stock, worth $161,100. This represents 0.02% of its overall portfolio holdings.

Number of Shares
399
Previous 399 -0.0%
Holding current value
$161,100
Previous $216,000 4.17%
% of portfolio
0.02%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 10, 2024

SELL
$497.49 - $547.8 $20,397 - $22,459
-41 Reduced 9.32%
399 $216,000
Q4 2023

Jan 17, 2024

SELL
$433.51 - $488.06 $42,483 - $47,829
-98 Reduced 18.22%
440 $207,000
Q3 2023

Oct 11, 2023

BUY
$414.13 - $475.93 $6,626 - $7,614
16 Added 3.07%
538 $234,000
Q2 2023

Jul 10, 2023

BUY
$436.33 - $496.2 $227,764 - $259,016
522 New
522 $231,000

Others Institutions Holding ELV

About Elevance Health, Inc.


  • Ticker ELV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Healthcare Plans
  • Shares Outstandng 240,000,992
  • Market Cap $96.9B
  • Description
  • Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions....
More about ELV
Track This Portfolio

Track Smith Anglin Financial, LLC Portfolio

Follow Smith Anglin Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smith Anglin Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Smith Anglin Financial, LLC with notifications on news.